As of January 2025 EyePoint Pharmaceuticals has a market cap of €0.57 Billion. This makes EyePoint Pharmaceuticals the world's 6546th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 22nd, 2025 the market cap of EyePoint Pharmaceuticals was reported to be: